Market World Continuous Renal Replacement Therapy Market | Page 2

Continuous renal replacement therapy (CRRT) is a widespread optimal for the cure of ICU patients with AKI,
particularly for hemodynamically unbalanced circumstances. CRRT consists of solute removal from blood by
hemofiltration or haemodialysis or a blend of both. CRRT is carried out for about 24 hours in an ICU, making it
relatively different from traditional renal replacement therapies that consist of intermittent haemodialysis
durable from four to six hours or even at a reduced rate. Therefore, CRRT was established in an effort to offer
artificial kidney support to those patients who could not abide the traditional haemodialysis as traditional
intermittent haemodialysis often causes hemodynamic instability in the critically ill patients. The patients in
receipt of CRRT can obtain as much as protein as well as fluid required achieving optimum nutrition.
There are many factors that propel the growth of Continuous Renal Replacement Therapy (CRRT) Market such
as rise in geriatric population, novel product launches, mounting occurrence of Acute Kidney Injury, patient’s
inclination towards Renal Replacement Therapy, awareness regarding the blood purification technique, and
development in technologies. On the other hand, there are factors that hinder the growth of the market like
high demand of skilled ICU nurses, high expenses on Continuous Renal Replacement Therapy and complications
of the therapy. The Continuous Renal Replacement Therapy (CRRT) Market can be classified on the basis
product, modality, and geography.
On the basis of product, Continuous Renal Replacement Therapy (CRRT) Market is classified as CRRT
Disposables, Hemofilters, Bloodlines, CRRT Systems, Dialysate and Replacement Fluids, and the other
Disposables. On the basis of modality, Continuous Renal Replacement Therapy (CRRT) Market is classified Slow
Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous
Hemodiafiltration (CVVHDF), and Continuous Venovenous Hemodialysis (CVVHD).
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/continuous-renal-replacement-therapy-crrt-market
On the basis of geography, Continuous Renal Replacement Therapy (CRRT) Market is classified as North America,
Europe, Asia Pacific, and Rest of the World. In 2015, the largest share was held by Europe tracked by North
America. Nevertheless, Asia Pacific’s market is anticipated to grow at the highest rate. The factors that attribute
to the high growth include developments in healthcare, increasing geriatric population, expanding sepsis
prevalence, and so on.
The prominent players that fuel the growth of Continuous Renal Replacement Therapy (CRRT) Market include
Infomed SA, Baxter International Inc., Medica S.p.A, Medical Components, Inc., Nikkiso Co., Ltd, NxStage
Medical, Inc., Toray Medical Company Limited, B. Braun Melsungen AG, BellcoS.r.l., Fresenius Medical Care AG
& Co. KGaA, and Asahi Kasei Medical Co., Ltd. Since 2014, Baxter International Inc., has dominated the
Continuous Renal Replacement Therapy (CRRT) Market.